Detalhe da pesquisa
1.
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.
Front Immunol
; 13: 910136, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911728
2.
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.
Sci Rep
; 11(1): 14917, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290317
3.
Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.
Front Immunol
; 12: 729837, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34603305